# Xermelo

NDC: 70720-125
Generic name: telotristat ethyl
Labeler / Manufacturer: TerSera Therapeutics LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201005

FDA application: NDA208794

## Active ingredients

- TELOTRISTAT ETHYL: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70720-125"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70720-125
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4ac9d62-887c-4c8f-b04d-a5f31cec7c86